Form D · Biotechnology
SpotitEarly, Inc.
Englewood, NJ · CIK 0002077992
Offering snapshot reported Aug 5, 2025 · SEC filing
- Reported sold
- $10K Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Jul 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 5, 2025 | Initial | $10,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-553660
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Aug 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ariel Ben Dayan | Director |
| Shai Lankry | Director, Executive, Promoter |
| J. Leonard Lichtenfeld | Executive |
| Alon Lifshitz | Director |
| Shlomi Madar | Director, Executive, Promoter |
| Roi Ophir | Director, Promoter |
| Assaf Ruf | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
61 W. Palisade Ave.
Englewood, NJ, 07631
Englewood, NJ, 07631